Health Care Drops on Rotation to Rate-Sensitive Sectors - Health Care Roundup

Health-care companies fell as traders rotated into sectors with more to gain from a moderation in interest rates.

Shares of Novo Nordisk and Eli Lilly continued their recent decent, as excitement about their obesity drugs cooled somewhat.

Consumer weight-loss firm WeightWatchers launched a subscription plan that will offer Novo Nordisk's Ozempic and other so-called GLP-1 drugs.

Moderna unveiled new data from a continuing early-stage trial of the personalized cancer treatment it is testing with Merck, saying that the updated results help build the case that the drug works.

Write to Rob Curran at [e-mail]

(END) Dow Jones Newswires

12-14-23 1741ET